DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kitazawa M, Katagiri T, Suzuki H. et al
A 52–week randomized controlled trial of ipragliflozin or sitagliptin in
type 2 diabetes combined with metformin: The N-ISM study.
Diabetes, Obesity and Metabolism 2021;
23: 811-821
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.